Original Papers - Prostate
Vol. 90 No. 1 (2018)
https://doi.org/10.4081/aiua.2018.1.40

The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH)

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 12 September 2017
Published: 31 March 2018
2059
Views
2189
Downloads
Benign prostatic hyperplasia, Lower urinary tract symptoms, Prostate artery embolization

Authors

Konstantinos Stamatiou
stamatiouk@gmail.com
Urology Department, Tzaneio Hospital, Piraeus, Greece.
Aim: Prostate artery embolization (PAE) is a non invasive modality for the treatment of benign prostate hypertrophy (BPH) related lower urinary tract symptoms (LUTS). As a relatively new procedure, data determining the clinical success is somehow scarce. In the present article we examine the current clinical outcome measures in order to identify the most accurate.
Results: Current imaging outcome measures are consistent with clinical ones only in the group of patients with adenomatous- dominant BPH while are inconsistent in patients with small sized adenomas.
Conclusions: Additional studies and/or evaluation tools are needed in order to provide accurate evaluation of clinical success in the subgroup of patients with non- adenomatous-dominant BPH while they may inspire new options and novel techniques for both BPH treatment and treatment-follow up.

Downloads

Download data is not yet available.

How to Cite



The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH). (2018). Archivio Italiano Di Urologia E Andrologia, 90(1), 40-43. https://doi.org/10.4081/aiua.2018.1.40

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.